Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Pinhasov

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|March 10, 2004
Protective peptides that are orally active and mechanistically nonchiralDouglas E Brenneman, Catherine Y Spong, Janet M Hauser, et al.
Scientific Reports|March 8, 2022
Antidepressant-like effects of a chlorogenic acid- and cynarine-enriched fraction from Dittrichia viscosa root extractKateryna Murlanova, Netanela Cohen, Anna Pinkus, et al.
Neuroreport|March 14, 2003
Injections of the neuroprotective peptide NAP to newborn mice attenuate head-injury-related dysfunction in adultsRoy Zaltzman, Sara M Beni, Eliezer Giladi, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 14, 2016
Seasonality and BDNF polymorphism influences depression outcome in patients with atopic dermatitis and psoriasisTatyana Vinnik, Michael Kirby, Maryia Bairachnaya, et al.
Neuroscience and Biobehavioral Reviews|June 29, 2007
Assessing activity onset time and efficacy for clinically effective antidepressant and antimanic drugs in animal models based on dominant-submissive relationshipsEwa Malatynska, Albert Pinhasov, Christopher J Creighton, et al.
Oncotarget|October 22, 2016
Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanomaBoris Redko, Helena Tuchinsky, Tamar Segal, et al.
Neuroscience Letters|February 23, 2026
Selective upregulation of fatty acid-binding protein 5 within the basolateral amygdala blunts stress-induced reinstatement of cocaine-seeking behavior in miceNicole Roeder, Aidan Powell, John Hamilton, et al.
Cancer Genomics & Proteomics|April 24, 2021
Differences in RNA and microRNA Expression Between PTCH1- and SUFU-mutated MedulloblastomaSivan Gershanov, Helen Toledano, Nomi Pernicone, et al.
Plos One|June 6, 2025
Cocaine self-administration attenuates brain glucose metabolism and functional connectivity in ratsChristopher Rowan, Colin Hanna, Munawwar Sajjad, et al.
International Journal of Molecular Sciences|September 10, 2021
Anti-Cancer Effects of Cyclic Peptide ALOS4 in a Human Melanoma Mouse ModelBar Levi, Shiri Yacobovich, Michael Kirby, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Pharmacology and Experimental Therapeutics|March 10, 2004
Protective peptides that are orally active and mechanistically nonchiralDouglas E Brenneman, Catherine Y Spong, Janet M Hauser, et al.
Scientific Reports|March 8, 2022
Antidepressant-like effects of a chlorogenic acid- and cynarine-enriched fraction from Dittrichia viscosa root extractKateryna Murlanova, Netanela Cohen, Anna Pinkus, et al.
Neuroreport|March 14, 2003
Injections of the neuroprotective peptide NAP to newborn mice attenuate head-injury-related dysfunction in adultsRoy Zaltzman, Sara M Beni, Eliezer Giladi, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 14, 2016
Seasonality and BDNF polymorphism influences depression outcome in patients with atopic dermatitis and psoriasisTatyana Vinnik, Michael Kirby, Maryia Bairachnaya, et al.
Neuroscience and Biobehavioral Reviews|June 29, 2007
Assessing activity onset time and efficacy for clinically effective antidepressant and antimanic drugs in animal models based on dominant-submissive relationshipsEwa Malatynska, Albert Pinhasov, Christopher J Creighton, et al.
Oncotarget|October 22, 2016
Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanomaBoris Redko, Helena Tuchinsky, Tamar Segal, et al.
Neuroscience Letters|February 23, 2026
Selective upregulation of fatty acid-binding protein 5 within the basolateral amygdala blunts stress-induced reinstatement of cocaine-seeking behavior in miceNicole Roeder, Aidan Powell, John Hamilton, et al.
Cancer Genomics & Proteomics|April 24, 2021
Differences in RNA and microRNA Expression Between PTCH1- and SUFU-mutated MedulloblastomaSivan Gershanov, Helen Toledano, Nomi Pernicone, et al.
Plos One|June 6, 2025
Cocaine self-administration attenuates brain glucose metabolism and functional connectivity in ratsChristopher Rowan, Colin Hanna, Munawwar Sajjad, et al.
International Journal of Molecular Sciences|September 10, 2021
Anti-Cancer Effects of Cyclic Peptide ALOS4 in a Human Melanoma Mouse ModelBar Levi, Shiri Yacobovich, Michael Kirby, et al.
Pageof 11